Aclaris Therapeutics
ACRS
ACRS
136 hedge funds and large institutions have $409M invested in Aclaris Therapeutics in 2026 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 41 increasing their positions, 40 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
11% more funds holding
Funds holding: 122 → 136 (+14)
3% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 40
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
136
Holding in Top 10
3
Calls
$2.57M
Puts
$1.14M
Top Buyers
| 1 | +$31.5M | |
| 2 | +$23M | |
| 3 | +$16.6M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$11.3M |
| 5 |
KCM
Kalehua Capital Management
Dallas,
Texas
|
+$6.18M |
Top Sellers
| 1 | -$7.5M | |
| 2 | -$4.03M | |
| 3 | -$2.26M | |
| 4 |
Renaissance Technologies
New York
|
-$2.1M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.97M |
